Fagerhult AB has successfully acquired 100% of Groupe Trato-TLV, strengthening its presence in the French lighting and medical sectors.
Information on the Target
The Groupe Trato-TLV, founded in 1947 in Roubaix by Michel Picha, is a notable industrial player in Northern France. Under the stewardship of Francis Picha for over three decades, and currently managed by his grandchildren, Guillaume and Charley Picha, the group has established a significant presence in the lighting and medical sectors. Employing approximately 230 personnel across three production sites, Trato-TLV generates an annual revenue of around €60 million, with nearly 20% derived from exports.
Trato-TLV operates through three main entities: 'Trato Industries', focusing on the lighting vertical, and 'TLV' and 'Biolume', both of which specialize in medical applications. Renowned for the quality of its products and the expertise of its teams, the company produces over 800,000 luminaires yearly, positioning itself as a reference in its industry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in France
The lighting and medical device industries in France are characterized by innovation and a strong push towards sustainability. The French lighting market is undergoing significant transformation, transitioning to energy-efficient solutions, and the demand for intelligent li
Similar Deals
SK Capital Partners → LISI Group's Medical division
2025
Asker Healthcare Group → Finmed SAS
2025
Fagerhult
invested in
Groupe Trato-TLV
in 2025
in a Buyout deal
Disclosed details
Revenue: $60M